Enyedy Mark J
Officer, Director at ImmunoGen, Inc.
- Sold, on record
- $53M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Feb 5, 2024
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ImmunoGen, Inc.Officer, Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ImmunoGen, Inc.Plan not statedFeb 22 2018
Sold 51,070 shares at $5.60 ($286k)
Enyedy Mark J, Chief Executive Officer
Sold 9.5% of holdings ($3M position)483,768 shares leftFiling
- 2 Form 4 sale ImmunoGen, Inc.Plan not statedFeb 24 +732 days
Sold 55,222 shares at $4.99 ($276k)
Enyedy Mark J, Chief Executive Officer
Sold 11.3% of holdings ($2.4M position)433,776 shares leftFirst sale on recordFiling
- 3 Form 144 notice ImmunoGen, Inc.NoticeAug 2 +1255 days
Filed to sell 995,157 shares ($17.4M)
Enyedy Mark J, Officer, Director
No 10b5-1 planFirst sale on recordFiling
- 4 Form 144 notice ImmunoGen, Inc.NoticeAug 3 +1 day
Filed to sell 1M shares ($16.9M)
Enyedy Mark J, Officer, Director
No 10b5-1 planFirst sale on recordFiling
- 5 Form 4 sale ImmunoGen, Inc.UnusualAug 4 +1 day
Sold 3M shares at $17.01 ($51.1M)
Enyedy Mark J, CHIEF EXECUTIVE OFFICER
No 10b5-1 planSold 84.5% of holdings ($60.6M position)553,270 shares leftFirst sale on recordFollows a Form 144Filing
- 6 Form 144 notice ImmunoGen, Inc.NoticeAug 4 same day
Filed to sell 992,397 shares ($16.8M)
Enyedy Mark J, Officer, Director
No 10b5-1 planFirst sale on recordFiling
- 7 Form 144 notice ImmunoGen, Inc.NoticeFeb 5 +185 days
Filed to sell 20,107 shares ($589k)
Enyedy Mark J, Officer, Director
10b5-1 planFiling
- 8 Form 4 sale ImmunoGen, Inc.RoutineFeb 5 same day
Sold 20,107 shares at $29.28 ($589k)
Enyedy Mark J, CHIEF EXECUTIVE OFFICER
10b5-1 planSold 3.3% of holdings ($17.7M position)584,397 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (9)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | ImmunoGen, Inc. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 20,107 | $589k | 3.3% | Routine | SEC |
| Feb 5, 2024 | ImmunoGen, Inc. | Officer, Director | Form 144 notice | 20,107 | $589k | Notice | SEC | |
| Aug 4, 2023 | ImmunoGen, Inc. | Officer, Director | Form 144 notice | 992,397 | $16.8M | Notice | SEC | |
| Aug 4, 2023 | ImmunoGen, Inc. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 3M | $51.1M | 84.5% | Unusual | SEC |
| Aug 3, 2023 | ImmunoGen, Inc. | Officer, Director | Form 144 notice | 1M | $16.9M | Notice | SEC | |
| Aug 2, 2023 | ImmunoGen, Inc. | Officer, Director | Form 144 notice | 995,157 | $17.4M | Notice | SEC | |
| Feb 24, 2020 | ImmunoGen, Inc. | Chief Executive Officer | Form 4 sale | 55,222 | $276k | 11.3% | Plan not stated | SEC |
| Feb 22, 2018 | ImmunoGen, Inc. | Chief Executive Officer | Form 4 sale | 51,070 | $286k | 9.5% | Plan not stated | SEC |
| Feb 21, 2018 | ImmunoGen, Inc. | Chief Executive Officer | Form 4 sale | 67,717 | $736k | 11.3% | Plan not stated | SEC |